← Back to Search

Ductal Carcinoma In Situ (DCIS) or invasive breast cancer for Ductal Carcinoma

N/A
Waitlist Available
Led By Chirag Shah, MD
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-treatment
Awards & highlights
No Placebo-Only Group

Summary

Microorganisms in the human body (such as virus, bacteria, fungus) may have an important role in breast cancer side effects. In this study, microorganisms will be analyzed to determine which, if any,are present. It will then be determined if side effects from breast radiation are associated with these microorganisms. Understanding the association of microorganisms with side effects will allow the study team to look at strategies to reduce side effects for patients undergoing radiation to the breast.

Eligible Conditions
  • Ductal Carcinoma
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Correlation of the microbiome to incidence of at least grade 3 skin toxicity using the CTCAE version 4.0 scoring
Microbiome profile as assessed by breast skin sample
Microbiome profile as assessed by stool sample

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ductal Carcinoma In Situ (DCIS) or invasive breast cancerExperimental Treatment2 Interventions
Participants with DCIS or invasive breast cancer

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
465 Previous Clinical Trials
32,562 Total Patients Enrolled
Chirag Shah, MDPrincipal InvestigatorThe Cleveland Clinic
2 Previous Clinical Trials
190 Total Patients Enrolled
~4 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top